Le Lézard
Classified in: Health, Science and technology
Subject: PER

Monica Chopra Joins Auxa Health as Co-Founder & CEO


Auxa Health's recently appointed CEO brings 20 years of experience to help transform the future of social care access.

NEW YORK, Nov. 30, 2022 /PRNewswire/ -- Auxa Health, a leading social care orchestration technology company, announced Monica Chopra, MBA, MPH as its Chief Executive Officer and Co-Founder. Ms. Chopra is a seasoned healthcare leader with over 22 years of industry experience across health systems, payers, digital health, and consulting. She joins Auxa from Oscar Health, where she served as Vice President, East Markets, leading their ACA and Medicare Advantage business lines across half of their operating states.

"Tens of billions of dollars of social care benefits go unused each year, while half of the adults in America report difficulty accessing housing, food, and social support. This needs to change and that's why I'm thrilled to join a company transforming the future of social care access," said Monica Chopra. "I look forward to partnering with healthcare organizations, across the country, to ensure individual social needs are addressed," she continued.

Auxa Health focuses on closing the gap on missed opportunities to receive social care resources. Health plans, along with state and federal agencies, offer a wide range of resources to address social needs. However, individuals, caregivers, and providers either remain unaware or have difficulty accessing the benefits available to them and their patients.

Auxa's technology ensures patients are connected to the resources they need. The company's end-to-end model includes simplifying access to social care benefit information, matching individuals to the right resources, and removing barriers to access and enrollment into relevant benefits.

"Monica has a vision for social care that is grounded in deep industry expertise," explained co-founder and Executive Chairman, Jeff De Flavio, MD, "She is the leader we need to operationalize social care in medicine today."

"Monica joining Auxa comes at a consequential moment in time as healthcare organizations today recognize the value of addressing social care needs and seek solutions to enable timely interventions," said Kevin Ryan, CEO and Founder of AlleyCorp. "I am delighted that she is willing to bring to bear her two decades of solution-oriented experience in healthcare to meet the moment for our aging generation."

About Auxa Health

Auxa Health is a VC-backed healthcare technology firm focused on social care orchestration. Our vision is a healthier, more equitable society which meets whole-person health needs beyond the traditional limitations of medical care and benefits. Auxa's tools, technology, and services proactively identify the right benefits for individuals and take on the work of enrollment. Our end-to-end support ensures that people are connected to the resources they need, while reducing the administrative burden for individuals, caregivers, and providers.

Learn more at auxahealth.com or write to [email protected]

About AlleyCorp

AlleyCorp founds and funds companies in New York. Unconstrained by industry, AlleyCorp originates the ideas, hires the early teams, funds, launches, and grows each company, and maintains an integral leadership role from beginning through exit. AlleyCorp companies have collectively raised more than $2B in venture capital and employ thousands of people in New York City and beyond. On the investment side, AlleyCorp is one of the most active early stage funds in New York. Every company it founds fuels a stronger foundation for new ideas and entrepreneurs.

Contact: [email protected]

SOURCE Auxa Health


These press releases may also interest you

at 07:45
Sensi.AI, a leader in AI-native, data, and analytics in senior care, today announced the appointment of in-home care leader Bob Roth to its Advisory Board. This partnership is an exciting validation of Sensi.AI's promise to enhance proactive,...

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...



News published on and distributed by: